Baxion
Screening
Tags
Alerts
Theme
Silence Therapeutics PLC
SLN
·
NASDAQ
·
$6.64
Share Price as of 11/2
·
$314M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/10/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/05/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Current report
10/19/26
8-K
Current report
08/12/26
8-K
Current report
08/10/26
8-K
Current report
08/10/26
8-K/A
Current report (amended)
07/16/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
08/12/26
S-3MEF
Prospectus / registration
08/11/26
424B5
Prospectus supplement
08/10/26
424B5
Prospectus supplement
05/27/26
S-3
Shelf registration
05/18/26
Proxies
Filter
DEFA14A
Additional proxy materials
10/19/26
DEFA14A
Additional proxy materials
10/19/26
DEF 14A
Definitive proxy
04/29/26
DEF 14A
Definitive proxy
05/16/25
PRE 14A
Preliminary proxy
05/06/25
Ownership
Filter
SC 13G
Beneficial ownership
10/13/26
SC 13G/A
Beneficial ownership (amended)
10/13/26
Form 4
Insider transaction
08/13/26
SC 13D/A
Beneficial ownership (amended)
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
Other
Filter
EFFECT
Request for effectiveness
05/27/26
CORRESP
Correspondence with the SEC
05/22/26
UPLOAD
Letter from the SEC
05/22/26
ARS
Annual report to shareholders
04/29/26
UPLOAD
Letter from the SEC
01/09/26
Latest Filings
Filter
8-K
Current report
10/19/26
DEFA14A
Additional proxy materials
10/19/26
DEFA14A
Additional proxy materials
10/19/26
8-K
Current report
08/12/26
424B5
Prospectus supplement
08/12/26
Ownership
Filter
SC 13G
Beneficial ownership
10/13/26
SC 13G/A
Beneficial ownership (amended)
10/13/26
Form 4
Insider transaction
08/13/26
SC 13D/A
Beneficial ownership (amended)
08/13/26
SC 13G/A
Beneficial ownership (amended)
08/13/26